Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Sep 10, 2013
Perrigo Company (NYSE: PRGO; TASE) today announced that it has received final approval from the U.S. Food and Drug Administration for its...
-
Sep 10, 2013
Perrigo Company (NYSE: PRGO; TASE) today announced that Perrigo Chairman, President and CEO Joseph C. Papa will present at the Morgan Stanley Global...
-
Aug 15, 2013- Fiscal fourth quarter net sales increased $135 million, or 16%, to $967 million.
Perrigo Company (NYSE: PRGO; TASE: PRGO) today announced results for its fourth quarter and fiscal year ended June 29, 2013. (Logo:...
-
Aug 14, 2013
Perrigo Company (NYSE: PRGO;TASE) today announced that its Board of Directors declared a quarterly dividend of $0.09 per share, payable on September...
-
Aug 12, 2013
Perrigo Company (NYSE: PRGO; TASE) today announced that it has received final approval from the U.S. Food and Drug Administration for its abbreviated...
-
Aug 12, 2013
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) and Perrigo Company (NYSE: PRGO;TASE) today announced the launch of the generic...
-
Aug 5, 2013
Perrigo Company (NYSE: PRGO; TASE) today announced that its infant formula division, Perrigo Nutritionals, is working with the American Academy of...
-
Aug 2, 2013Company also Announces Plans to Conduct its Analyst Day After Completion of Elan Corporation Acquisition
Perrigo Company (NYSE: PRGO, "Perrigo") today announced that it it will release financial results for its fourth quarter and fiscal year 2013 and...
-
Jul 31, 2013
Perrigo Company (NYSE: PRGO; TASE) today announced that it has received final approval for its abbreviated new drug application for fluticasone...